Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convalescent Plasma for COVID-19 Research (CONCOR) Donor Study

NCT04555109 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT04555109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04555109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convalescent Plasma for COVID-19 Research (CONCOR) Donor Study
Lead sponsor
The Hospital for Sick Children
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2020
Completion date
October 31, 2022
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19